US3012964A
(en)
|
1958-06-24 |
1961-12-12 |
Universal Oil Prod Co |
Hydrocarbon oil composition
|
US3022077A
(en)
|
1958-09-15 |
1962-02-20 |
Doonan William |
Arrowhead construction
|
JP2610889B2
(ja)
|
1987-09-03 |
1997-05-14 |
日本臓器製薬株式会社 |
新規架橋アデニン誘導体
|
WO1998001448A1
(fr)
|
1996-07-03 |
1998-01-15 |
Japan Energy Corporation |
Nouveaux derives de purine
|
BR9711970A
(pt)
|
1996-08-28 |
1999-08-24 |
Pfizer |
Derivados 6,5-substitu¡do-heterobic¡clicos
|
CN1083841C
(zh)
|
1996-10-04 |
2002-05-01 |
杏林制药株式会社 |
吡唑并吡啶基哒嗪酮衍生物及其制备方法
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6339089B2
(en)
|
1997-08-13 |
2002-01-15 |
Fujirebio Inc. |
Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
|
US6329381B1
(en)
|
1997-11-28 |
2001-12-11 |
Sumitomo Pharmaceuticals Company, Limited |
Heterocyclic compounds
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
ATE245641T1
(de)
|
1998-02-17 |
2003-08-15 |
Tularik Inc |
Antivirale pyrimidinderivate
|
US6110929A
(en)
|
1998-07-28 |
2000-08-29 |
3M Innovative Properties Company |
Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
|
JP4342007B2
(ja)
|
1998-08-10 |
2009-10-14 |
大日本住友製薬株式会社 |
キナゾリン誘導体
|
JP4315300B2
(ja)
|
1998-08-10 |
2009-08-19 |
大日本住友製薬株式会社 |
新規なキナゾリン誘導体
|
ES2221414T3
(es)
|
1998-08-27 |
2004-12-16 |
Sumitomo Pharmaceuticals Company, Limited |
Derivados de pirimidina.
|
US6583148B1
(en)
|
1999-04-08 |
2003-06-24 |
Krenitsky Pharmaceuticals, Inc. |
Neurotrophic substituted pyrimidines
|
CA2323008C
(fr)
|
1999-10-11 |
2005-07-12 |
Pfizer Inc. |
Composes pharmaceutiques actifs
|
WO2002088079A2
(fr)
|
2001-05-01 |
2002-11-07 |
Bristol-Myers Squibb Company |
Inhibiteurs doubles de pde 7 et pde 4
|
AU2002364211A1
(en)
|
2001-12-21 |
2003-07-15 |
Bayer Pharmaceuticals Corporation |
Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
|
US7091232B2
(en)
|
2002-05-21 |
2006-08-15 |
Allergan, Inc. |
4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
|
TW200407143A
(en)
|
2002-05-21 |
2004-05-16 |
Bristol Myers Squibb Co |
Pyrrolotriazinone compounds and their use to treat diseases
|
US7524852B2
(en)
|
2002-06-07 |
2009-04-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Bicyclic pyrimidine derivatives
|
AU2003271064B2
(en)
|
2002-09-27 |
2010-06-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel adenine compound and use thereof
|
US8455458B2
(en)
|
2002-10-16 |
2013-06-04 |
Arthrodynamic Technologies, Animal Health Division, Inc. |
Composition and method for treating connective tissue damage
|
EA200600069A1
(ru)
|
2003-06-20 |
2006-08-25 |
Коли Фармасьютикал Гмбх |
Низкомолекулярные антагонисты toll-подобных рецепторов (tlr)
|
ES2342069T4
(es)
|
2003-09-05 |
2011-01-26 |
Anadys Pharmaceuticals, Inc. |
Ligandos de tlr7 para el tratamiento de la hepatitis c.
|
CA2559036C
(fr)
|
2004-03-26 |
2013-08-20 |
Dainippon Sumitomo Pharma Co., Ltd. |
Compose 8-oxoadenine 9-substitue
|
WO2005092892A1
(fr)
|
2004-03-26 |
2005-10-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
Compose 8-oxoadenine
|
WO2007084413A2
(fr)
|
2004-07-14 |
2007-07-26 |
Ptc Therapeutics, Inc. |
Procedes de traitement de l’hepatite c
|
JP5031564B2
(ja)
|
2004-08-10 |
2012-09-19 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Hiv抑制1,2,4−トリアジン−6−オン誘導体
|
WO2006050843A1
(fr)
|
2004-11-09 |
2006-05-18 |
F. Hoffmann-La Roche Ag |
Composes aminoquinazolines
|
US7498409B2
(en)
|
2005-03-24 |
2009-03-03 |
Schering Corporation |
Screening assay for TLR7, TLR8 and TLR9 agonists and antagonists
|
JP2008540396A
(ja)
|
2005-05-04 |
2008-11-20 |
ファイザー・リミテッド |
癌およびc型肝炎などのウイルス感染を治療するためのトール様受容体調節薬としての2−アミド−6−アミノ−8−オキソプリン誘導体
|
ATE541848T1
(de)
|
2005-05-05 |
2012-02-15 |
Ardea Biosciences Inc |
Diaryl-purin, azapurine und deazapurine als nichtnukleoside reverse-transkriptase-inhibitoren zur behandlung von hiv
|
AR054122A1
(es)
|
2005-05-12 |
2007-06-06 |
Tibotec Pharm Ltd |
Pirido[2,3-d]pirimidas utiles como inhibidores de hcv, y metodos para la preparacion de las mismas
|
US7994360B2
(en)
|
2005-05-16 |
2011-08-09 |
Xtl Biopharmaceuticals Ltd. |
Benzofuran compounds
|
TW201402124A
(zh)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
作為類鐸受體(toll-like receptor)調節劑之8-經取代苯并氮雜呯
|
JP4850911B2
(ja)
|
2005-09-01 |
2012-01-11 |
エフ.ホフマン−ラ ロシュ アーゲー |
P2x3およびp2x2/3モジュレーターとしてのジアミノピリミジン
|
JPWO2007034881A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規アデニン化合物
|
US20070099941A1
(en)
|
2005-11-02 |
2007-05-03 |
Cytovia, Inc. |
N-arylalkyl-thienopyrimidin-4-amines and analogs as activators of caspases and inducers of apoptosis and the use thereof
|
WO2007063934A1
(fr)
|
2005-12-02 |
2007-06-07 |
Mitsubishi Tanabe Pharma Corporation |
Compose heterocyclique alicyclique
|
ES2374455T3
(es)
|
2006-02-17 |
2012-02-16 |
Pfizer Limited |
Derivados de 3-deazapurinza como moduladores de tlr7.
|
WO2008009077A2
(fr)
|
2006-07-20 |
2008-01-24 |
Gilead Sciences, Inc. |
Dérivés quinazoline 4,6-disubstitués et 2,4,6-trisubstitués et compositions pharmaceutiques utiles pour traiter des infections virales
|
US9259426B2
(en)
|
2006-07-20 |
2016-02-16 |
Gilead Sciences, Inc. |
4,6-di- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections
|
WO2008073785A2
(fr)
|
2006-12-07 |
2008-06-19 |
Genentech, Inc. |
Composés inhibiteurs de la phosphoinositide 3-kinase et procédés d'utilisation
|
JP2010513450A
(ja)
|
2006-12-20 |
2010-04-30 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー |
抗ウイルス性インドール
|
ES2552471T3
(es)
|
2007-02-07 |
2015-11-30 |
The Regents Of The University Of California |
Conjugados de agonistas de TLR sintéticos y usos de los mismos
|
JP2008222557A
(ja)
|
2007-03-08 |
2008-09-25 |
Kotobuki Seiyaku Kk |
ピロロ[3,2−d]ピリミジン誘導体及びこれを有効成分とする医薬組成物
|
EP2132209B8
(fr)
|
2007-03-19 |
2014-04-16 |
AstraZeneca AB |
Composés 8-oxo-adenine 9 substitué comme modulateurs du récepteur de type toll (tlr7)
|
PE20081887A1
(es)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Nuevo compuesto de adenina
|
EP2138497A4
(fr)
|
2007-03-20 |
2012-01-04 |
Dainippon Sumitomo Pharma Co |
Nouveau composé d'adénine
|
CA2687821C
(fr)
|
2007-05-22 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Inhibiteurs de benzimidazolone chymase
|
CN101784548B
(zh)
|
2007-06-29 |
2013-07-17 |
吉里德科学公司 |
嘌呤衍生物及其作为toll样受体7的调节剂的用途
|
CN101842098A
(zh)
|
2007-08-10 |
2010-09-22 |
基因实验室技术有限公司 |
用于治疗病毒感染的含氮的二环化学实体
|
WO2009032668A2
(fr)
|
2007-08-28 |
2009-03-12 |
Irm Llc |
Composés et compositions en tant qu'inhibiteurs de kinase
|
WO2009030998A1
(fr)
|
2007-09-05 |
2009-03-12 |
Coley Pharmaceutical Group, Inc. |
Composés pyrimidine utilisés comme agonistes du récepteur de type toll (tlr)
|
PE20091236A1
(es)
|
2007-11-22 |
2009-09-16 |
Astrazeneca Ab |
Derivados de pirimidina como immunomoduladores de tlr7
|
BRPI0821836A2
(pt)
|
2007-12-24 |
2015-06-16 |
Tibotec Pharm Ltd |
Indóis macrocíclicos como inibidores do vírus da hepatite c
|
AU2009210655B2
(en)
|
2008-02-07 |
2013-08-15 |
Telormedix Sa |
Treatment of bladder diseases with a TLR7 activator
|
WO2009134624A1
(fr)
|
2008-04-28 |
2009-11-05 |
Merck & Co., Inc. |
Inhibiteurs de la protéase hcv ns3
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
UY31982A
(es)
|
2008-07-16 |
2010-02-26 |
Boehringer Ingelheim Int |
Derivados de 1,2-dihidropiridin-3-carboxamidas n-sustituidas
|
WO2010014913A1
(fr)
|
2008-08-01 |
2010-02-04 |
Ventirx Pharmaceuticals, Inc. |
Formulations d'agoniste des récepteurs de type toll et leur utilisation
|
EA201101650A1
(ru)
|
2009-05-21 |
2012-07-30 |
Астразенека Аб |
Новые производные пиримидина и их применение в лечении злокачественных новообразований и последующих заболеваний
|
US8637525B2
(en)
|
2009-07-31 |
2014-01-28 |
Bristol-Myers Squibb Company |
Compounds for the reduction of beta-amyloid production
|
TWI468402B
(zh)
|
2009-07-31 |
2015-01-11 |
必治妥美雅史谷比公司 |
降低β-類澱粉生成之化合物
|
WO2011049987A2
(fr)
|
2009-10-20 |
2011-04-28 |
Eiger Biopharmaceuticals, Inc. |
Azaindazoles pour traiter une infection par le virus flaviviridae
|
ES2644286T3
(es)
|
2009-10-22 |
2017-11-28 |
Gilead Sciences, Inc. |
Derivados de purina o deazapurina útiles para el tratamiento de (entre otros) infecciones víricas
|
KR101094446B1
(ko)
|
2009-11-19 |
2011-12-15 |
한국과학기술연구원 |
단백질 키나아제 저해활성을 가지는 2,4,7-치환된 티에노[3,2-d]피리미딘 화합물
|
JP2013032290A
(ja)
|
2009-11-20 |
2013-02-14 |
Dainippon Sumitomo Pharma Co Ltd |
新規縮合ピリミジン誘導体
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
MX351464B
(es)
|
2010-10-01 |
2017-10-16 |
Ventirx Pharmaceuticals Inc Star |
El uso de un agonista del receptor 8 tipo toll para el tratamiento de enfermedades alérgicas.
|
WO2012066335A1
(fr)
|
2010-11-19 |
2012-05-24 |
Astrazeneca Ab |
Composés phénol en tant qu'agonistes du récepteur 7 de type toll
|
WO2012067269A1
(fr)
|
2010-11-19 |
2012-05-24 |
Dainippon Sumitomo Pharma Co., Ltd. |
Composés aminoalcoxyphényle et leur utilisation dans le traitement de maladies
|
DK2694484T3
(en)
|
2011-04-08 |
2018-11-05 |
Janssen Sciences Ireland Uc |
PYRIMIDINE DERIVATIVES FOR TREATING VIRUS INFECTIONS
|
SI2709989T1
(en)
*
|
2011-05-18 |
2018-04-30 |
Janssen Sciences Ireland Uc |
Quinazoline derivatives for the treatment of viral infections and other diseases
|
PL2776439T3
(pl)
|
2011-11-09 |
2018-12-31 |
Janssen Sciences Ireland Uc |
Pochodne puryny do leczenia zakażeń wirusowych
|
AU2013218072B2
(en)
|
2012-02-08 |
2017-08-31 |
Janssen Sciences Ireland Uc |
Piperidino-pyrimidine derivatives for the treatment of viral infections
|
PL3459942T3
(pl)
|
2012-04-24 |
2021-10-11 |
Vertex Pharmaceuticals Incorporated |
Inhibitory DNA-PK
|
UA113651C2
(xx)
|
2012-07-13 |
2017-02-27 |
|
Макроциклічні пурини для лікування вірусних інфекцій
|
ES2707885T3
(es)
|
2012-08-10 |
2019-04-05 |
Janssen Sciences Ireland Unlimited Co |
Alquilpirimidinderivados para el tratamiento de infecciones víricas y otras enfermedades
|
BR112015004205B1
(pt)
|
2012-08-28 |
2022-02-01 |
Janssen Sciences Ireland Uc |
Sulfamoil-arilamidas, seu uso das mesmas como medicamentos para o tratamento da hepatite b, composição farmacêutica que as compreende e produto
|
EP2712866A1
(fr)
|
2012-10-01 |
2014-04-02 |
Centre National de la Recherche Scientifique (CNRS) |
Dérivés de 1,2,4-triazine pour le traitement d'infections virales
|
SG11201502589YA
(en)
|
2012-10-05 |
2015-04-29 |
Janssen Sciences Ireland Uc |
Acylaminopyrimidine derivatives for the treatment of viral infections and further diseases
|
PT2906563T
(pt)
|
2012-10-10 |
2018-05-23 |
Janssen Sciences Ireland Uc |
Derivados de pirrolo[3,2-d]pirimidina para o tratamento de infeções virais e outras doenças
|
NZ748345A
(en)
|
2012-11-16 |
2020-04-24 |
Janssen Sciences Ireland Uc |
Heterocyclic substituted 2-amino-quinazoline derivatives for the treatment of viral infections
|
KR102225233B1
(ko)
|
2013-02-21 |
2021-03-09 |
얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 |
바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체
|
PT2978429T
(pt)
|
2013-03-29 |
2017-05-24 |
Janssen Sciences Ireland Uc |
Deaza-purinonas macrocíclicas para o tratamento de infeções virais
|
JO3603B1
(ar)
|
2013-05-17 |
2020-07-05 |
Janssen Sciences Ireland Uc |
مشتقات سلفامويل بيرولاميد واستخدامها كادوية لمعالجة التهاب الكبد نوع بي
|
EA034674B1
(ru)
|
2013-05-24 |
2020-03-05 |
Янссен Сайенсиз Айрлэнд Юси |
Производные пиридона для лечения нарушений, в которое вовлечены модуляции tlr7 и/или tlr8
|
PL3030563T3
(pl)
*
|
2013-06-27 |
2018-01-31 |
Janssen Sciences Ireland Uc |
Pochodne pirolo [3,2-d] pirymidyny do leczenia zakażeń wirusowych i innych chorób
|
EA036162B1
(ru)
|
2013-07-30 |
2020-10-08 |
Янссен Сайенсиз Айрлэнд Юси |
Производные тиено[3,2-d]пиримидинов для лечения вирусных инфекций
|
US9701661B2
(en)
|
2014-07-11 |
2017-07-11 |
Northwestern University |
2-imidazolyl-pyrimidine scaffolds as potent and selective inhibitors of neuronal nitric oxide synthase
|
HUE038059T2
(hu)
*
|
2015-03-04 |
2018-10-29 |
Gilead Sciences Inc |
Toll-like receptor moduláló 4,6-diamino-pirido[3,2-D]pirimidin vegyületek
|
AR107633A1
(es)
|
2016-02-19 |
2018-05-16 |
Hoffmann La Roche |
Procedimiento para la preparación del ácido 4-fenil-5-alcoxicarbonil-2-tiazol-2-il-1,4-dihidropirimidin-6-il-[metil]-3-oxo-5,6,8,8a-tetrahidro-1h-imidazo[1,5a]pirazin-2-il-carboxílico
|
JP2019511542A
(ja)
|
2016-04-15 |
2019-04-25 |
ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー |
カプシド集合阻害剤を含む組み合わせ及び方法
|
CN109476675B
(zh)
|
2016-07-01 |
2022-12-09 |
爱尔兰詹森科学公司 |
用于治疗病毒性感染的二氢吡喃并嘧啶衍生物
|
EP3507276B1
(fr)
*
|
2016-09-02 |
2021-11-03 |
Gilead Sciences, Inc. |
Composés modulateurs du recepteur de type toll
|